
Marconi Abreu MD
Diabetes, Lipid Metabolism
Medical Director Parkland Endocrinology Clinic
Join to View Full Profile
- 5323 Harry Hines BoulevardDallas, TX 75390 
- Phone+1 214-645-2800 
- Fax+1 214-645-8697 
Dr. Abreu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Marconi Abreu, MD, is a Dallas-based endocrinologist specializing in diabetes and lipid metabolism. He completed his Internal Medicine Residency at the University of Connecticut (2004 - 2007) and his Endocrinology, Diabetes, and Metabolism Fellowship at University of Texas Southwestern Medical Center (2012 - 2015). Dr. Abreu exhibits expertise in handling conditions like diabetes mellitus, obesity-related disorders, lipid metabolism disorders, osteoporosis, and polycystic ovarian syndrome. He's widely published on these topics in reputable journals, including significant contributions on diabetes technology, medication adherence and outcomes in type 2 diabetes. Additionally, he participated in creating SIMPLE, a clinical study focusing on a Basal Insulin Titration regimen for dealing with Type 2 Diabetes.
Education & Training
 University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015 University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015
 University of ConnecticutResidency, Internal Medicine, 2004 - 2007 University of ConnecticutResidency, Internal Medicine, 2004 - 2007
 Federal University of Bahia Faculty of MedicineClass of 2002 Federal University of Bahia Faculty of MedicineClass of 2002
Certifications & Licensure
 TX State Medical License 2014 - 2026 TX State Medical License 2014 - 2026
 MA State Medical License 2008 - 2013 MA State Medical License 2008 - 2013
 American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Internal Medicine
 American Board of Internal Medicine Endocrinology, Diabetes and Metabolism American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
Publications & Presentations
PubMed
- Impact of glucagon-like-peptide-1 receptor agonist therapy on pulmonary function in people with cystic fibrosis who achieve normal body mass index.Andrew Horvit, Katie Kaput, Amber Neece, Jessica Abramowitz, Marconi Abreu
 Journal of Cystic Fibrosis. 2025-10-17
- Use of commercially available automated insulin delivery systems in pregnant people with type 1 diabetes.Angela Q Pham, Ildiko Lingvay, Nicole Ahmadi, Patricia C Santiago-Munoz, Marconi Abreu
 Diabetes Research and Clinical Practice. 2025-10-01
- Incretin-based therapies for individuals with obesity and heart failure with mildly reduced or preserved ejection fraction: A systematic review and meta-analysis of ra...Thomaz Alexandre Costa, Nicole Felix, Gabriel Cavalcante Lima Chagas, Santiago Teran, Madelyn Boslough
 Diabetes, Obesity & Metabolism. 2025-09-01
Press Mentions
 UTSW Endocrinologists Find Paralysis Disorder May Be Underdiagnosed Among Hispanic MenMay 8th, 2023 UTSW Endocrinologists Find Paralysis Disorder May Be Underdiagnosed Among Hispanic MenMay 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









